Clinical trial
An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery
NCT01791322 is registered in ClinicalTrials.gov with Fore Biotherapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study to Assess the Oncogenic Status of Colorectal Cancer Patients That Have Undergone Surgery
- Lead sponsor
- Fore Biotherapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- June 30, 2016
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patients eligible for tumor biopsy, patients that have been diagnosed with colorectal cancer